Concentrix (NASDAQ:CNXC – Get Free Report) posted its earnings results on Tuesday. The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.65 by ($0.04), FiscalAI reports. The business had revenue of $2.50 billion for the quarter, compared to analysts’ expectations of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.Concentrix’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.79 EPS.
Here are the key takeaways from Concentrix’s conference call:
- Our AI/iX suite momentum accelerated — wins with technology rose ~61% YoY, signed annual contract value for AI-inclusive solutions more than doubled in Q1, and management expects iX Hero ARR to reach or exceed $100M by year-end.
- Q1 revenue was approximately $2.5 billion (CC +1.9%), adjusted EBITDA was $348M (13.9% margin) and non-GAAP EPS was $2.61 in line with guidance; adjusted FCF was negative $145M due to seasonal AR timing but full-year FCF guidance remains $630M–$650M.
- Management is taking cost actions and restructuring to drive about $40M of annualized savings, expects sequential margin expansion in 2H26, and targets reducing net leverage to below 2.6x adjusted EBITDA by year-end.
- Performance was uneven by vertical — banking/BFSI grew ~13% and retail/travel ~6%, but technology/consumer electronics and healthcare each fell ~6% due to lighter volumes and onshore mix, posing short-term revenue risk in those areas.
Concentrix Trading Down 6.8%
Shares of Concentrix stock opened at $24.67 on Thursday. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.40 and a current ratio of 1.18. The company has a market capitalization of $1.51 billion, a P/E ratio of -1.14, a PEG ratio of 0.28 and a beta of 0.50. Concentrix has a 1 year low of $24.27 and a 1 year high of $66.00. The company’s fifty day moving average is $35.01 and its two-hundred day moving average is $40.22.
Concentrix Dividend Announcement
Insider Activity at Concentrix
In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of Concentrix stock in a transaction dated Thursday, January 29th. The stock was acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. This represents a 0.28% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.
Institutional Trading of Concentrix
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Larson Financial Group LLC lifted its position in Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after acquiring an additional 479 shares during the period. Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the period. Global Retirement Partners LLC raised its stake in shares of Concentrix by 1,032.5% during the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after purchasing an additional 795 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Concentrix during the third quarter worth approximately $69,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Concentrix during the fourth quarter worth $100,000. 90.34% of the stock is owned by hedge funds and other institutional investors.
Concentrix News Roundup
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Top-line growth and steady outlook — Revenue rose 5.4% year-over-year to $2.50B and the company maintained full‑year 2026 revenue and non‑GAAP EPS ranges, showing underlying demand. Concentrix Reports First Quarter 2026 Results
- Positive Sentiment: Dividend retained — Board declared a $0.36 quarterly dividend (≈5.3% yield), which supports income-oriented holders. Dividend Announcement
- Neutral Sentiment: Share repurchase program ongoing — Company repurchased ~1M shares in Q1 at an average ~$40 and still has ~$396.6M authorization remaining (timing/opportunistic). Q1 Results / Buybacks
- Neutral Sentiment: Some analysts still rate CNXC a buy/outperform despite cuts to price targets — Barrington, Canaccord and Baird trimmed targets but kept bullish stances, leaving mixed signals for investors. Analyst Price Target Changes — Benzinga
- Negative Sentiment: EPS miss and margin compression — Reported GAAP diluted EPS collapsed to $0.33; non‑GAAP EPS missed by ~$0.04. Operating income fell ~30% year-over-year and adjusted EBITDA/margins declined, signaling meaningful profit pressure. Q1 Results — Financials
- Negative Sentiment: Weak cash flow — Operating cash flow was negative and adjusted free cash flow was a use (~$145M), heightening leverage and execution concerns during a costly AI transition. Q1 Cash Flow Summary — QuiverQuant
- Negative Sentiment: Cautious guidance & margin worries drove the sell‑off — Coverage cites a margin squeeze and conservative near‑term guidance as the primary reasons for sharp share weakness. Why Concentrix Is Down — Yahoo Finance
- Negative Sentiment: Investor sentiment weakened — Some research and commentary downgraded conviction (Seeking Alpha downgrade / cautious op-eds) and the stock hit a one‑year low after the print. Seeking Alpha Downgrade New 1-Year Low — AmericanBankingNews
Analysts Set New Price Targets
A number of analysts have weighed in on CNXC shares. Canaccord Genuity Group cut their price objective on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday. Robert W. Baird dropped their target price on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research report on Wednesday. Barrington Research cut their price target on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating on the stock in a research note on Wednesday. Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Finally, Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Concentrix currently has a consensus rating of “Hold” and a consensus target price of $48.50.
Check Out Our Latest Stock Analysis on CNXC
Concentrix Company Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Articles
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
